DNA flow cytometry in primary breast carcinoma.

Area of Science:

• Oncology
• Cell Biology
• Biomedical Science

Background:

• DNA content analysis using flow cytometry is a key method in cancer research.
• Tumor ploidy, reflecting the chromosomal content of cancer cells, is an important prognostic factor.
• The S-phase fraction, representing cells undergoing DNA synthesis, is associated with tumor proliferation.

Purpose of the Study:

• To investigate the relationship between DNA ploidy, S-phase fraction, and clinicopathological features in primary breast carcinomas.
• To determine if DNA flow cytometry parameters correlate with tumor stage, grade, estrogen receptor status, and menopausal status.

Main Methods:

• Flow cytometry was used to analyze DNA content in 66 primary breast carcinoma samples.
• Tumors were classified as diploid or non-diploid based on DNA content.
• S-phase fraction was calculated for each tumor.
• Statistical analysis was performed to correlate ploidy and S-phase fraction with clinical stage, histological grade, estrogen receptor status, and menopausal status.

Main Results:

• Of 66 primary breast carcinomas, 26 were diploid and 40 were non-diploid.
• Non-diploid tumors exhibited significantly larger S-phase fractions ( > 10%) compared to diploid tumors.
• High tumor ploidy showed a positive correlation with advanced clinical stage (Stage I vs. Stage ≥ II).
• High tumor ploidy was also positively associated with high histological grade.
• No significant correlation was found between tumor ploidy and estrogen-receptor content or menopausal status.

Conclusions:

• Non-diploid DNA content in breast cancer is associated with increased cellular proliferation, as indicated by a larger S-phase fraction.
• Tumor ploidy is a valuable indicator of aggressive tumor behavior, correlating with higher clinical stage and histological grade.
• These findings highlight the prognostic significance of DNA flow cytometry in breast cancer management.